MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-WB-10-0016596
Jajodia Pharmaceuticals Pvt.Ltd.
Jajodia Pharmaceuticals Pvt.Ltd. - pharma in Kolkata, West Bengal, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹14.1 Lakh
▲ 70% YoY
Net profit · FY 2025
₹2.82 Lakh
Net margin 20%
EBITDA · FY 2025
₹4.54 Lakh
EBITDA margin 32.2%
Authorised capital
₹20 Lakh
Registered with MCA
Paid-up capital
₹12.85 Lakh
Issued & subscribed
Company age
34 yrs
Est. 1992
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date
About Jajodia Pharmaceuticals Pvt.Ltd.
Data last updated:
Jajodia Pharmaceuticals Pvt.Ltd. is a private limited company based in Kolkata, West Bengal, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 November 1992 and has been in existence for over 34 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24232WB1992PTC056987.
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹12.85 Lakh. It is led by directors Anil Kumar Murarka and Nisha Murarka.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Diamondprestige41 – A A.J.C.Boseroad3Rdfloor Suiteno.301, Kolkata, West Bengal, India – 700017.
As per the financials filed for FY 2025, the company reported a revenue of ₹14.1 Lakh, a growth of 70% compared to the previous year. For the same year it recorded a net profit of ₹2.82 Lakh (net margin 20%) and EBITDA of ₹4.54 Lakh (EBITDA margin 32.2%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 31% over five years.
Jajodia Pharmaceuticals Pvt.Ltd. is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-WB-10-0016596). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24232WB1992PTC056987
Registration Number 056987
Incorporation Date 16 November 1992
ROC Kolkata
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-WB-10-0016596
Recognitions & Rankings of Jajodia Pharmaceuticals
Contact details
Jajodia Pharmaceuticals Pvt.Ltd.'s registered office is in Kolkata, West Bengal. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressDiamondprestige41 – A A.J.C.Boseroad3Rdfloor Suiteno.301, Kolkata, West Bengal, India – 700017
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Jajodia Pharmaceuticals Pvt.Ltd., buy the company report.
Comprehensive company report
Jajodia Pharmaceuticals Pvt.Ltd. - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Financials of Jajodia Pharmaceuticals Pvt.Ltd.
FY 2025 filings availableJajodia Pharmaceuticals Pvt.Ltd. reported revenue of ₹14.1 Lakh (up 70% YoY) for FY 2025.
Revenue · FY 2025
₹14.1 Lakh ▲ 70%
Net profit · FY 2025
₹2.82 Lakh margin 20%
EBITDA · FY 2025
₹4.54 Lakh margin 32.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 70%
3 years · compounded
▼ 7%
5 years · compounded
▲ 31%
EBITDA CAGR growth
1 year
▲ 121%
3 years · compounded
▼ 32%
5 years · compounded
▲ 29%
Revenue has grown at a compounded annual rate (CAGR) of 31% over five years, including 70% growth in the latest year. EBITDA rose 121% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.54 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.82 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 32.2% | ||||
| Net Profit Margin | 20% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Jajodia Pharmaceuticals Pvt.Ltd., buy the company report.
Board of directors of Jajodia Pharmaceuticals Pvt.Ltd.
Jajodia Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anil Kumar Murarka Also directs: Nexome Capital Markets Limited, Presidency Commercial Private Limited, Viewpoint Vintrade Private Limited and 1 more | Director | 04 Mar 2002 | 24 Years 7 Months | Current |
| Nisha Murarka | Director | 23 Mar 2002 | 24 Years 7 Months | Current |
Peer comparison
Jajodia Pharmaceuticals Pvt.Ltd. is compared with the 10 companies closest to it by revenue in the Outsourcing industry (Consulting Services, Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Nilpa Software Systems Private Limited | ₹14.11 Lakh (FY 2024) | -52.0% | Ahmedabad, Gujarat, India | |||
| Innova Technology Solutions Mysore Private Limited | ₹14.11 Lakh (FY 2025) | 12.0% | Karnataka, India | |||
| Syence Pharmaceuticals Private Limited | ₹14.1 Lakh (FY 2025) | Mumbai, Maharashtra, India | ||||
| Jwala Multi Management India Private Limited | ₹14.1 Lakh (FY 2025) | -2.0% | Gurugram, Haryana, India | |||
| Amvision Pharmaceuticals Private Limited | ₹14.1 Lakh (FY 2024) | 1.0% | Chennai, Tamil Nadu, India | |||
| Jajodia Pharmaceuticals Pvt.Ltd.this company | ₹14.1 Lakh (FY 2025) | ₹2.82 Lakh | 20% | 70.0% | Kolkata, West Bengal, India | |
| Dinsha Pharmaceuticals Private Limited | ₹14.1 Lakh (FY 2025) | 5.0% | Thane, Maharashtra, India | |||
| Wansol Pharmaceuticals Private Limited | ₹14.09 Lakh (FY 2025) | Akola, Maharashtra, India | ||||
| Shuchi Management Consultancy Services Private Limited | ₹14.09 Lakh (FY 2024) | 48.0% | Chennai, Tamil Nadu, India | |||
| Reth Pharmaceuticals Private Limited | ₹14.08 Lakh (FY 2025) | -2.0% | Kondhwa Bk, Gokul Nagar, Maharashtra, India | |||
| Researco Techconsultancy Private Limited | ₹14.08 Lakh (FY 2024) | 23.0% | Kanpur, Uttar Pradesh, India |
To see the full peer comparison of Jajodia Pharmaceuticals Pvt.Ltd., buy the company report.
Auditor
Jajodia Pharmaceuticals Pvt.Ltd. is audited by R K DOSHI & ASSOCIATES for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R K DOSHI & ASSOCIATES | FY 2019 | 323771E |
Shareholding
The shareholding of Jajodia Pharmaceuticals Pvt.Ltd. is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Jajodia Pharmaceuticals Pvt.Ltd., buy the company report.
Legal cases
No court or tribunal cases involving Jajodia Pharmaceuticals Pvt.Ltd. are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Jajodia Pharmaceuticals Pvt.Ltd.; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Jajodia Pharmaceuticals Pvt.Ltd.; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Jajodia Pharmaceuticals Pvt.Ltd. has 2 board changes on record since 2002: 2 appointments. The latest: Nisha Murarka was appointed as Director on 23 Mar 2002.
AGM
Jajodia Pharmaceuticals Pvt.Ltd. last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Jajodia Pharmaceuticals Pvt.Ltd. has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata.
Appointed
Nisha Murarka was appointed as Director.
Appointed
Anil Kumar Murarka was appointed as Director.
Incorporation
16 Nov 1992
Jajodia Pharmaceuticals Pvt.Ltd. was registered on 16 Nov 1992 with Roc Kolkata & aged 33 years 11 months as per MCA records.
Frequently asked questions
Jajodia Pharmaceuticals is an active private limited company based in Kolkata, West Bengal, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 16 November 1992 (34+ years old) and is registered under CIN U24232WB1992PTC056987.
Jajodia Pharmaceuticals has 2 current directors:
- Anil Kumar Murarka - Director
- Nisha Murarka - Director
The latest financial statements of Jajodia Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Jajodia Pharmaceuticals is U24232WB1992PTC056987. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Jajodia Pharmaceuticals was incorporated on 16 November 1992, making it 34+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Jajodia Pharmaceuticals by revenue are Nilpa Software Systems Private Limited, Innova Technology Solutions Mysore Private Limited, Syence Pharmaceuticals Private Limited, Jwala Multi Management India Private Limited, Amvision Pharmaceuticals Private Limited and 5 more, all in the Outsourcing industry (Consulting Services, Pharmaceuticals).
Nisha Murarka was appointed as Director on 23 Mar 2002. Anil Kumar Murarka was appointed as Director on 04 Mar 2002.
Yes, Jajodia Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-WB-10-0016596).
The registered office of Jajodia Pharmaceuticals is at Diamondprestige41 – A A.J.C.Boseroad3Rdfloor Suiteno.301, Kolkata, West Bengal, India – 700017.
Jajodia Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Jajodia Pharmaceuticals is compliant as of 15 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages